SCHEMBL19497952

SCHEMBL19497952

C=CC(=O)COCCCOc1ccc(C(=O)Oc2ccc(-c3ccc(CCC)cc3)c(C=N)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ THRB P10828 5/20 0.40
▸ PRSS1 P07477 1/20 0.37
▸ ACR P10323 1/20 0.37
▸ KMT2A Q03164 3/20 0.36
▸ RARB P10826 1/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ PTPN11 Q06124 2/20 0.35
▸ NFKB1 P19838 1/20 0.34
▸ NFKB2 Q00653 1/20 0.34
▸ RELA Q04206 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19497859 0.88 MAPT (0.45) MAPTSMN1; SMN2THRBPRSS1ACR
SCHEMBL19497949 0.87 MAPT (0.42) MAPTSMN1; SMN2THRBPRSS1ACR
SCHEMBL19497864 0.86 MAPT (0.45) MAPTSMN1; SMN2THRBPRSS1ACR
SCHEMBL18200278 0.85 MAPT (0.44) MAPTSMN1; SMN2THRBPRSS1ACR
SCHEMBL19497950 0.80 MAPT (0.46) MAPTSMN1; SMN2THRBPRSS1ACR
SCHEMBL18904643 0.80 MAPT (0.37) MAPTSMN1; SMN2THRBPRSS1ACR
SCHEMBL19497953 0.78 MAPT (0.46) MAPTSMN1; SMN2THRBPRSS1ACR
SCHEMBL19497907 0.78 MAPT (0.45) MAPTSMN1; SMN2THRBPRSS1ACR
SCHEMBL19771135 0.77 THRB (0.46) THRBRARBLMNAPTPN11ALDH1A1
SCHEMBL19497942 0.76 ALDH1A1 (0.40) MAPTSMN1; SMN2THRBKMT2ARARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10723952-B2 Polymerizable compound and optically anisotropic body DIC CORPORATION (JP) 2020-07-28 — — US disclosed
US-20170306233-A1 POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY DIC CORPORATION (JP) 2017-10-26 — — US disclosed
US-20170306233-A1 POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY DIC CORPORATION (JP) 2017-10-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170306233-A1 POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY SMC4, PHOSPHO1, SMCHD1 MAPT 21/4885SMN1; SMN2 1598/4885THRB 4883/4885
US-10723952-B2 Polymerizable compound and optically anisotropic body SMC4, SMCHD1, PHOSPHO1 MAPT 17/4885SMN1; SMN2 1468/4885THRB 4884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback